If you are demanding any product or service please register as Farmavita.Net network member and publish your offer or demad. In-Licensing and oursoucing of products is usual a way for development of winning portfolio of products. License-in is also very cost effective way of product/technology development. Opportunities are listed according chronological order, the most recent first.

Oncology Generics Demand

Popular

Description

Expanding U.S. generic oncology company seeks CTDs or MA-approved products with dossiers and manufacturing supplier that could pass a FDA inspection leading to approvals in U.S. and Europe. Company's strength is in oncology marketing and sales, and FDA regulatory affairs, so we need partners who can reliably supply the U.S. (North American) oncology market. We are looking for "old drugs" such as Doxorubicin, Cisplatin, Daunorubicin, Cytarabine, etc. as well as "new drugs" such as Docetaxel, Oxaliplatin, Gemcitabine, Pemetrexed, Imatinib and others.

We are will to pay up-front fees, approval milestones, and transfer fees.

Contact is: jasinkule@gmail.com or phone is: 1 (480) 427-2026  

More details

Name Description
Pharma licensing In-licensing (demand)

Ad details

Ad ID : 797

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

Active substance formulated into Tivortin®  –...
34 Views
I’m a representative of Parafarm (Penza,...
885 Views
Nonclinical study Tacrolimus caps. 0,5; 1,0; 5,0
740 Views
Profitable and Modern Russian CMO with long...
698 Views
Adalimumab API available: - from EU cGMP...
10434 Views
Infliximab API available: - from EU cGMP...
701 Views